Device litigation · Monthly update

Nexplanon lawsuit update: October 2026

What court records and Organon's own filings show, and what the 2026 label change says.

Checked October 29, 2026

See counsel side by side Check the docket

Where things stand

There is no federal Nexplanon MDL or class action as of October 2026. Organon's June 30, 2026 quarterly report lists one Nexplanon case, in California state court. In March 2026, Organon agreed to settle claims by 56 plaintiffs and claimants over Implanon, for a confidential amount. In January 2026, the FDA added a boxed warning about insertion and removal complications.

No Nexplanon MDL appears on the JPML's list of active dockets as of October 1, 2026.
Organon reports one Nexplanon case in California state court, two filed Implanon cases in Ohio federal court, and 56 unfiled Implanon claims under a tolling agreement (as of June 30, 2026).
On March 12, 2026, Organon signed a settlement with 56 plaintiffs and claimants for a payment it called "confidential, but non-material."
The January 2026 label approves Nexplanon for up to 5 years and adds a boxed warning about improper insertion and removal.
Since August 23, 2026, providers must be certified in the NEXPLANON REMS program to obtain and insert the implant.

Docket summary

Nexplanon (etonogestrel implant)

Docket number: No MDL as of October 1, 2026
Venue: One Nexplanon case in California state court, per Organon
Pending: 1 U.S. Nexplanon case (counted June 30, 2026)
Next scheduled event: No trial date found in public records
Current posture: Organon settled 56 Implanon claims on March 12, 2026; no Nexplanon settlement reported

Data source

Firms handling these cases

Law firms that advertise Nexplanon cases among the firms we reviewed.
Firm name	Suited to	Established	Headquarters	Court-appointed posts	Fees
1 Schmidt & Clark, LLP	A free review of a Nexplanon insertion, removal or migration injury, with intake from every state and a 24/7 phone line	2005	Washington, DC	No court appointment located	Free case review, with a phone line open 24/7

Is there a Nexplanon lawsuit?

There is no large, coordinated Nexplanon case. The JPML’s October 1, 2026 list of active MDLs includes no Nexplanon or etonogestrel docket. The JPML’s panel-orders page shows none either.

Individual cases do exist. Nexplanon is a birth control implant made by Organon. Merck is also named as a defendant in some cases. Organon’s quarterly report for the period ending June 30, 2026 describes the U.S. cases it faces.

Case type	Where	Count (as of June 30, 2026)
Nexplanon product case	California state court	1
Implanon product liability actions (filed)	U.S. District Court, N.D. Ohio	2
Implanon claims (unfiled, under a tolling agreement)	Not filed in court	56

A tolling agreement pauses the filing deadline while the parties talk. It lets a claim stay alive without a lawsuit.

The March 2026 settlement

On March 12, 2026, Organon signed a Master Settlement Agreement. Under it, 56 plaintiffs and claimants will release their filed and unfiled claims. Organon calls the payment “confidential, but non-material.” In a company filing, “non-material” means the company does not view the amount as significant to its finances.

The settlement relates to Implanon, another Organon implant. We could not confirm whether the California Nexplanon case is part of it. Organon has not reported any settlement of Nexplanon claims. Prior results do not guarantee a similar outcome.

Cases outside the U.S.

Organon’s filing also reports 19 cases pending against Merck outside the U.S., as of June 30, 2026. Seven involve Implanon and 12 involve Nexplanon.

A separate securities case

Organon also faces a consolidated securities class action. The court consolidated it on March 6, 2026. A May 8, 2026 amended complaint added claims about “the Nexplanon matter.” This is an investor lawsuit. It is not a personal injury case, and it does not pay patients.

The January 2026 label change

The FDA-approved label now lists several “Recent Major Changes” dated January 2026. They cover the indication, dosing and administration, and two warnings (sections 5.1 and 5.2). The label was last revised in May 2026.

What changed	What the label now says
How long it can be used	Approved to prevent pregnancy “for up to 5 years”
Boxed warning	“Risk of Complications Due to Improper Insertion and Removal”
Who can provide it	Available only through a restricted program, the NEXPLANON REMS
Warning 5.1	Insertion and removal complications, including “migration to vasculature, including pulmonary vessels”

A boxed warning sits in a box at the top of the prescribing information. A REMS is a safety program required by the FDA.

Warning 5.1 lists symptoms that may follow migration into blood vessels. They include chest pain, shortness of breath (dyspnea), cough and coughing up blood (hemoptysis). The label says surgery may be needed to remove the implant in those cases.

What the REMS means for patients

The REMS had a six-month transition period. It ended on August 23, 2026. Since then, a provider must be certified in the REMS program to obtain and insert Nexplanon, according to the California Medical Association.

For patients, this means the clinician who places the implant should be certified under the program. If you have questions about your implant, ask your doctor. This page does not give medical advice.

What the label change does and does not mean

A label change is a regulatory step. It is not a court finding that Organon did anything wrong. No court has found Organon or Merck liable for a Nexplanon injury in the records we reviewed.

The label change does put certain risks in writing. People who had a hard removal, an implant that moved, or surgery to find the implant may want to know their options. A lawyer can explain whether a claim makes sense on your facts. Filing deadlines depend on your state. Some states start the clock on the date of injury. Others, in some cases, start it when the injury was discovered. A lawyer can confirm which deadline applies in your state.

Timeline

Date	Event
January 2026	FDA label changes: up to 5 years of use, boxed warning, REMS
March 6, 2026	Organon securities class action consolidated
March 12, 2026	Organon signs settlement with 56 Implanon plaintiffs and claimants
May 2026	Label revision date; May 8 amended securities complaint mentions “the Nexplanon matter”
June 30, 2026	Organon reports one U.S. Nexplanon case, in California state court
August 23, 2026	REMS transition ends; providers must be certified
October 1, 2026	No Nexplanon MDL on the JPML’s active list

We will update this page if a Nexplanon MDL is requested or if Organon reports new cases. For other device cases, see our October 2026 update on all device lawsuits.

Firm profiles

Schmidt & Clark, LLP

Suited to: A free review of a Nexplanon insertion, removal or migration injury, with intake from every state and a 24/7 phone line

Schmidt & Clark is a plaintiffs' firm that represents injured people nationwide in individual cases. Most of its work is in mass torts: defective products, medical devices, harmful drugs and toxic exposure.

Schmidt & Clark lists Nexplanon among the device cases it takes. Of the eight device firms we review on this site, it is the only one whose case list includes Nexplanon.

Headquarters: Washington, DC
Established: 2005
Fees: Free case review, with a phone line open 24/7
Case types on its website: hernia mesh, spinal cord stimulators, Philips CPAP, Bard PowerPort, IVC filters, and Nexplanon

Awards

The firm says Best Lawyers included it on the 2026 "Best Law Firms" list. Citation
C.L. Mike Schmidt, a partner, is board certified by the Texas Board of Legal Specialization in Civil Trial Law and in Personal Injury Trial Law, and by the National Board of Trial Advocacy in Civil Trial. Citation
The firm says Super Lawyers has selected it for 19 straight years. Citation

Questions to raise

Its website lists no individual verdict or settlement figures. Ask what results it has had in cases like yours.
Ask whether the firm would keep your case or refer it to co-counsel. Referral is common in mass torts.

Website: schmidtandclark.com

Each outcome above is drawn from the firm's own published record or from court filings. Prior results do not guarantee a similar outcome.

Citations

Reader questions

Is there a Nexplanon class action lawsuit?

No. We found no Nexplanon class action or MDL as of October 1, 2026. Organon reports one Nexplanon product case in the U.S., filed in California state court.

Has there been a Nexplanon settlement?

Not that Organon has reported. On March 12, 2026, Organon signed a settlement with 56 plaintiffs and claimants over Implanon claims. It called the payment confidential and non-material. Prior results do not guarantee a similar outcome.

What is the Nexplanon boxed warning?

The boxed warning is titled "Risk of Complications Due to Improper Insertion and Removal." It appears on the label with changes dated January 2026. Nexplanon is now available only through a restricted program called the NEXPLANON REMS.

Can a Nexplanon implant move inside the body?

The label lists "migration to vasculature, including pulmonary vessels" among insertion and removal complications. Symptoms it lists include chest pain, shortness of breath, cough and coughing up blood. It says surgery may be needed to remove the implant. Talk to your doctor if you have symptoms.

Is there a deadline to file a Nexplanon lawsuit?

Yes. Personal injury deadlines are set by state law and vary. Some states start the clock on the date of injury and others on the date it was discovered. Ask a lawyer to confirm the deadline in your state.